One-year data from a large real-world dataset provide reassurance that clinical outcomes with the new-generation LAA occlusion device for stroke prevention compare well with those from pivotal trials.
SURPASS Study Confirms Real-World Safety and Efficacy of Watchman FLX Through 45 Days
Interim data from a large real-world dataset provide reassurance about acute and subacute procedural outcomes with the new-generation LAA occlusion device for stroke prevention.
Insights From 1,000+ Left Atrial Appendage Closure Procedures With Watchman
Our world-leading experience in this procedure confirms that it reduces stroke risk in high-risk patients and can be safely combined with TAVR as well as atrial fibrillation ablation.
‘Convergent Plus’ Optimizes Hybrid Strategy for Persistent Atrial Fibrillation
Our surgeons and electrophysiologists have given the hybrid Convergent procedure for persistent AF a new twist by adding ablation of the ligament of Marshall and a left atrial appendage clip.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
3 Things Heart Surgeons Need to Know About the Maze Procedure (Video)
In this three-minute captioned video, Dr. Marc Gillinov brings clarity to three common questions surrounding surgical treatment of atrial fibrillation.
Genetic Control of Left Atrial Gene Expression: A New Window into AFib Risk
A new study identified genes and genetic variations associated with 12 loci linked to risk for atrial fibrillation. The result is a genome-wide catalog to facilitate follow-on investigations.